# Lockheed Martin Corp: overview

LMT · NYSE · CIK 936468 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lmt.md) · [Financials](/companies/lmt/financials.md) · [Filings](/companies/lmt/filings.md) · [Insiders](/companies/lmt/insiders.md)

Latest reported revenue: [$20.71bn](/filings/0001628280-26-066928.md) for Q3 FY2026, three months to 2026-09-27, from the 10-Q filed Oct 22, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-066928).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [18.6 d](/filings/0001628280-26-004195.md) | [18.0](/filings/0001628280-26-026836.md) | [18.2](/filings/0001628280-26-049411.md) | [18.6](/filings/0001628280-26-066928.md) | [20.3 d](/filings/0001628280-26-004195.md) | [18.0](/filings/0001628280-26-026836.md) | [20.1](/filings/0001628280-26-049411.md) | [20.7](/filings/0001628280-26-066928.md) |
| Gross margin | % | [3.7% d](/filings/0001628280-26-004195.md) | [12.9%](/filings/0001628280-26-026836.md) | [4.0%](/filings/0001628280-26-049411.md) | [12.0%](/filings/0001628280-26-066928.md) | [11.4% d](/filings/0001628280-26-004195.md) | [11.5%](/filings/0001628280-26-026836.md) | [12.2%](/filings/0001628280-26-049411.md) | [11.8%](/filings/0001628280-26-066928.md) |
| Operating margin | % | [3.7% d](/filings/0001628280-26-004195.md) | [13.2%](/filings/0001628280-26-026836.md) | [4.1%](/filings/0001628280-26-049411.md) | [12.3%](/filings/0001628280-26-066928.md) | [11.5% d](/filings/0001628280-26-004195.md) | [11.4%](/filings/0001628280-26-026836.md) | [12.4%](/filings/0001628280-26-049411.md) | [11.8%](/filings/0001628280-26-066928.md) |
| Net margin | % | [2.8% d](/filings/0001628280-26-004195.md) | [9.5%](/filings/0001628280-26-026836.md) | [1.9%](/filings/0001628280-26-049411.md) | [8.7%](/filings/0001628280-26-066928.md) | [6.6% d](/filings/0001628280-26-004195.md) | [8.3%](/filings/0001628280-26-026836.md) | [9.2%](/filings/0001628280-26-049411.md) | [8.9%](/filings/0001628280-26-066928.md) |
| Diluted EPS | $ per share | not reported | [7.28](/filings/0001628280-26-026836.md) | [1.46](/filings/0001628280-26-049411.md) | [6.95](/filings/0001628280-26-066928.md) | not reported | [6.44](/filings/0001628280-26-026836.md) | [7.94](/filings/0001628280-26-049411.md) | [7.97](/filings/0001628280-26-066928.md) |
| Free cash flow | $bn | [0.4 d](/filings/0001628280-26-004195.md) | [1.0](/filings/0001628280-26-026836.md) | [(0.2) d](/filings/0001628280-26-049411.md) | [3.3 d](/filings/0001628280-26-066928.md) | [2.8 d](/filings/0001628280-26-004195.md) | [(0.3)](/filings/0001628280-26-026836.md) | [2.9 d](/filings/0001628280-26-049411.md) | [3.0 d](/filings/0001628280-26-066928.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [67.0](/filings/0000936468-24-000010.md) | [66.0](/filings/0000936468-25-000009.md) | [67.6](/filings/0001628280-26-004195.md) | [71.0](/filings/0001628280-26-004195.md) | [75.0](/filings/0001628280-26-004195.md) |
| Gross margin | % | [13.5%](/filings/0000936468-24-000010.md) | [12.6%](/filings/0000936468-25-000009.md) | [12.5%](/filings/0001628280-26-004195.md) | [9.8%](/filings/0001628280-26-004195.md) | [10.2%](/filings/0001628280-26-004195.md) |
| Operating margin | % | [13.6%](/filings/0000936468-24-000010.md) | [12.7%](/filings/0000936468-25-000009.md) | [12.6%](/filings/0001628280-26-004195.md) | [9.9%](/filings/0001628280-26-004195.md) | [10.3%](/filings/0001628280-26-004195.md) |
| Net margin | % | [9.4%](/filings/0000936468-24-000010.md) | [8.7%](/filings/0000936468-25-000009.md) | [10.2%](/filings/0001628280-26-004195.md) | [7.5%](/filings/0001628280-26-004195.md) | [6.7%](/filings/0001628280-26-004195.md) |
| Diluted EPS | $ per share | [22.76](/filings/0000936468-24-000010.md) | [21.66](/filings/0000936468-25-000009.md) | [27.55](/filings/0001628280-26-004195.md) | [22.31](/filings/0001628280-26-004195.md) | [21.49](/filings/0001628280-26-004195.md) |
| Free cash flow | $bn | [7.7](/filings/0000936468-24-000010.md) | [6.1](/filings/0000936468-25-000009.md) | [6.2](/filings/0001628280-26-004195.md) | [5.3](/filings/0001628280-26-004195.md) | [6.9](/filings/0001628280-26-004195.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lmt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $16.80bn | 32,975,170 |  | Added +419,582 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $9.62bn | 18,877,978 |  | Added +1,045,265 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $7.21bn | 14,158,758 |  | Added +93,270 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $3.98bn | 7,806,000 |  | Added +653,551 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.91bn | 5,706,408 |  | Added +41,551 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.83bn | 5,559,369 |  | Added +228,784 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.66bn | 5,216,758 |  | Added +144,356 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $1.24bn | 2,426,642 |  | Added +467,153 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $1.16bn | 2,284,661 |  | Reduced −411,028 |
| [Sanders Capital, LLC](/funds/1508097.md) | 2026-06-30 | $1.07bn | 2,093,533 |  | Added +952,510 |

## Recent filings

[All 1,750 filings](/companies/lmt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 17:13 ET | [10-Q](/filings/0001628280-26-066928.md) | Quarterly report, period 2026-09-27 | 0001628280-26-066928 |
| 2026-10-22 | 06:26 ET | [8-K](/filings/0001628280-26-066780.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-066780 |
| 2026-08-28 | 19:31 ET | [8-K](/filings/0001193125-26-371750.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-371750 |
| 2026-07-23 | 16:38 ET | [10-Q](/filings/0001628280-26-049411.md) | Quarterly report, period 2026-06-28 | 0001628280-26-049411 |
| 2026-07-23 | 06:30 ET | [8-K](/filings/0001628280-26-049277.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-049277 |
| 2026-05-13 | 18:19 ET | [8-K](/filings/0000936468-26-000011.md) | 5.07 Shareholder vote results | 0000936468-26-000011 |
| 2026-04-23 | 16:09 ET | [10-Q](/filings/0001628280-26-026836.md) | Quarterly report, period 2026-03-29 | 0001628280-26-026836 |
| 2026-04-23 | 06:36 ET | [8-K](/filings/0001628280-26-026683.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-026683 |
| 2026-03-26 | 08:02 ET | [DEF 14A](/filings/0000936468-26-000004.md) | Proxy statement, period 2026-05-12 | 0000936468-26-000004 |
| 2026-01-29 | 17:18 ET | [10-K](/filings/0001628280-26-004195.md) | Annual report, period 2025-12-31 | 0001628280-26-004195 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-004195.md), filed Jan 29, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 936468
- Tickers: LMT
- Exchange: NYSE
- SIC code: 3760 Guided Missiles & Space Vehicles & Parts
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 18:13 ET. No prices; not investment advice.